Skip to content

What is the Edinburgh scale assessment: A comprehensive guide to the EPDS

6 min read

Studies show that at least 10–20% of women experience some form of postpartum depression, a distressing condition more prolonged than the temporary 'baby blues'. The Edinburgh Postnatal Depression Scale (EPDS), or Edinburgh scale assessment, is a widely used, 10-question tool designed to help healthcare professionals and new mothers identify potential symptoms of perinatal depression, including during both pregnancy and the postnatal period.

Quick Summary

The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire for screening perinatal depression. This tool helps identify individuals at risk of depression during or after pregnancy, assessing mood, anxiety, and anhedonia over the past week.

Key Points

  • Screening tool, not diagnostic: The Edinburgh scale assessment (EPDS) is a 10-item questionnaire used to screen for perinatal depression, not to provide a definitive diagnosis.

  • Focuses on psychological symptoms: Unlike other scales, the EPDS excludes somatic symptoms of depression that can be confused with normal postpartum physical changes, focusing instead on psychological and mood-related indicators.

  • Scoring indicates risk: A total score of 10 or more may indicate possible depression, while a score of 13 or more suggests probable depression.

  • Immediate attention for self-harm: A score of 1 or more on question 10, which addresses suicidal thoughts, requires immediate clinical assessment and intervention.

  • Validated for pregnancy and postpartum: The EPDS is effective for screening depressive symptoms during both the antenatal and postnatal periods.

  • Not specific to culture/language: The original scale's colloquial language can be a limitation, necessitating culturally sensitive translations to ensure accuracy in diverse populations.

In This Article

Understanding the Edinburgh Postnatal Depression Scale (EPDS)

The Edinburgh scale assessment, formally known as the Edinburgh Postnatal Depression Scale (EPDS), is a crucial tool in maternal mental health. Developed in 1987 in Edinburgh, Scotland, it was specifically designed to help primary care providers detect if mothers were experiencing postnatal depression. The scale has since become the most commonly used screening tool globally for this purpose, with its use validated during both pregnancy (antenatal) and the period after childbirth (postpartum).

The EPDS is a self-administered questionnaire that takes just a few minutes to complete. Its design is intentional, focusing on the psychological and mood-related symptoms of depression rather than the physical, somatic symptoms (like changes in sleep or appetite) that can be easily confused with the normal effects of childbirth. By focusing on mood, anxiety, and anhedonia (the inability to feel pleasure), the EPDS provides a more specific screen for perinatal depression.

How the Edinburgh scale assessment works

Administering and scoring the EPDS is a straightforward process, though the interpretation of results requires clinical judgment.

  • The questions: The scale consists of 10 statements that the individual rates based on how they have felt over the last seven days. The four response options for each question are scored from 0 to 3, with higher numbers indicating more severe symptoms.
  • Scoring: Some questions are reverse-scored, which can be a point of confusion and a source of potential errors if not done carefully. The final score is a sum of the points from all 10 questions, with a maximum possible score of 30.
  • Interpreting the score: A total score of 10 or higher may suggest possible depression, while a score of 13 or higher often indicates probable depression of varying severity. However, the most critical item is question 10, which addresses suicidal thoughts. Any score of 1 or more on this item warrants immediate clinical assessment.

Comparison with other screening tools

While the EPDS is highly regarded, other tools are also used for perinatal depression screening. It is helpful to understand the differences.

Feature Edinburgh Postnatal Depression Scale (EPDS) Patient Health Questionnaire-9 (PHQ-9)
Focus Specifically designed for perinatal (antenatal and postpartum) depression, focusing more on mood and anxiety symptoms. Developed for the general population and based on DSM-IV criteria for major depression, covering a broader range of symptoms.
Somatic Symptoms Excludes somatic symptoms (e.g., changes in appetite, sleep) that can overlap with normal pregnancy/postpartum experiences. Includes somatic symptoms, which some studies suggest can make it less specific for PPD if not interpreted carefully.
Length 10 items, quick and easy to complete. 9 items, also quick to complete, and has a shorter 2-item version (PHQ-2) often used for initial screening.
Cultural Sensitivity Originally in British English, requiring careful, culturally sensitive translation for different populations to ensure accuracy. Items are phrased more plainly in American English, making them often easier to translate accurately across different cultures.
Validation Widely validated globally and considered a gold standard for perinatal screening. Also validated for perinatal use, with studies showing comparable or slightly different performance characteristics.

The importance of the assessment

Early detection of perinatal depression is critical for the well-being of both the mother and the infant. Untreated maternal depression can lead to negative long-term consequences for the mother, baby, and the entire family. The EPDS provides a quick, systematic way for healthcare providers to identify individuals who need further evaluation.

  • Identifying those at risk: The EPDS helps clinicians identify those who may be struggling but have not disclosed their symptoms. The American Academy of Pediatrics (AAP) and American College of Obstetricians and Gynecologists (ACOG) recommend its use for routine screening.
  • Providing a basis for discussion: A high EPDS score provides an opportunity to begin a more in-depth conversation with the patient about their mental health. This formal screening can help initiate a dialogue that might otherwise not happen.
  • Measuring severity: The scale's scoring system can provide an indication of the severity of the depressive symptoms, which can help guide treatment decisions, from counseling to more intensive interventions for moderate or severe cases.
  • Not a diagnostic tool: It is crucial to remember that the EPDS is a screening tool, not a diagnostic instrument. A high score warrants a careful clinical assessment by a trained professional to confirm a diagnosis and develop a treatment plan.

Limitations and considerations

Despite its widespread use, the EPDS has some limitations.

  • Not a diagnostic tool: As mentioned, a high score doesn't automatically mean a diagnosis of depression. A professional clinical interview is always required to confirm a diagnosis.
  • Language and cultural differences: The original British English colloquialisms can be confusing in other languages or even in American English, potentially impacting accuracy. Culturally sensitive translations and adaptations, such as the EPDS-US, have been developed to address this.
  • Focus on depression: The scale does not effectively screen for other conditions that can co-occur, such as anxiety neuroses, phobias, or personality disorders.
  • Risk of mis-scoring: Because of the reverse-scored questions, there is a risk of scoring errors, especially in busy clinical settings.

Conclusion

The Edinburgh scale assessment is a foundational tool for screening perinatal depression, enabling healthcare professionals to efficiently and effectively identify new and expectant mothers who may be at risk. Its brevity, focus on psychological symptoms, and global validation have made it invaluable in promoting maternal mental health. However, its use should always be followed by clinical judgment and a comprehensive assessment, as it is a screening instrument and not a definitive diagnostic test. By using this tool and understanding its purpose and limitations, providers can help ensure that women receive timely and appropriate care, improving health outcomes for both mother and child.

For more information on supporting new mothers and addressing perinatal mental health, resources are available from reputable organizations such as Postpartum Support International.

Frequently Asked Questions (FAQs)

How long does the Edinburgh scale assessment take to complete?

Most individuals can complete the Edinburgh Postnatal Depression Scale (EPDS) in less than five minutes, making it a quick and efficient screening tool for use in clinical settings.

What do the scores on the EPDS mean?

Scoring above 9 generally suggests a high chance of perinatal depression, while a score of 13 or more may indicate a more significant depressive illness. However, any score should be followed by a clinical evaluation to confirm a diagnosis.

Can men take the Edinburgh scale assessment?

While originally designed for mothers, some researchers have explored using the EPDS for paternal depression. However, specific scoring recommendations for men are not uniform, and other screening tools designed for the general population, like the PHQ-9, may be more appropriate.

Can the Edinburgh scale assessment be used during pregnancy?

Yes, the EPDS has been validated for use during both the postpartum period and during pregnancy (antenatal) to screen for depressive symptoms.

Is the EPDS a diagnostic tool?

No, the EPDS is a screening tool, not a diagnostic instrument. It is used to identify individuals who may need further assessment, but a formal clinical evaluation by a healthcare professional is necessary to make a diagnosis.

Is the Edinburgh scale free to use?

Yes, the Edinburgh Postnatal Depression Scale (EPDS) is free to use and reproduce, provided the copyright and authors are acknowledged. Many healthcare providers offer it, and it can also be found online.

What should be done if an individual scores high on the EPDS?

If an individual scores high on the EPDS, it indicates a need for follow-up. This should include a careful clinical assessment by a healthcare professional, such as a doctor or mental health specialist, to confirm any potential diagnosis and discuss a treatment plan. Immediate attention is required if there is any indication of self-harm.

Frequently Asked Questions

Most individuals can complete the Edinburgh Postnatal Depression Scale (EPDS) in less than five minutes, making it a quick and efficient screening tool for use in clinical settings.

Scoring above 9 generally suggests a high chance of perinatal depression, while a score of 13 or more may indicate a more significant depressive illness. However, any score should be followed by a clinical evaluation to confirm a diagnosis.

While originally designed for mothers, some researchers have explored using the EPDS for paternal depression. However, specific scoring recommendations for men are not uniform, and other screening tools designed for the general population, like the PHQ-9, may be more appropriate.

Yes, the EPDS has been validated for use during both the postpartum period and during pregnancy (antenatal) to screen for depressive symptoms.

No, the EPDS is a screening tool, not a diagnostic instrument. It is used to identify individuals who may need further assessment, but a formal clinical evaluation by a healthcare professional is necessary to make a diagnosis.

Yes, the Edinburgh Postnatal Depression Scale (EPDS) is free to use and reproduce, provided the copyright and authors are acknowledged. Many healthcare providers offer it, and it can also be found online.

If an individual scores high on the EPDS, it indicates a need for follow-up. This should include a careful clinical assessment by a healthcare professional, such as a doctor or mental health specialist, to confirm any potential diagnosis and discuss a treatment plan. Immediate attention is required if there is any indication of self-harm.

In the UK, it is common for health visitors to administer the EPDS multiple times during the first 6–8 months after birth. Screening can also occur during pregnancy and at routine postnatal check-ups.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.